TherapeuticsMD, Inc. — Director's Dealing 2021

Aug 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2021-08-13

Reporting Person: Thompson Tommy G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-13	Common Stock	P	11000	$0.87	Acquired	715600	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	148851	Direct
Common Stock	1001	Indirect

Footnotes

F1: The reported securities are owned by Thompson Family Investments, LLC, an entity solely owned by Thompson Family Holdings, LLC, an entity solely owned by Mr. Thompson.

F2: The reported securities are owned by Thompson Family Holdings, LLC, an entity solely owned by Mr. Thompson.